​

Funding Round

Series A - Metsera

Series A - Metsera

Investment Firm

Overview

Metsera operates as a clinical-stage biopharmaceutical company.

Announced Date

Apr 18, 2024

Funding Type

Series A

Highlights

Location

New York, New York, United States, North America

Social

N/A

Investor Lead

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorMubadala Capital Ventures
Participant InvestorNewpath Management
Participant InvestorF-Prime Capital
Participant InvestorGoogle Ventures
Participant InvestorARCH Venture Partners

Round Details and Background

Metsera raised $290000000 on 2024-04-18 in Series A

Metsera operates as a clinical-stage biopharmaceutical company.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 18, 2024
Series A - Metsera
6-290.0M
Apr 18, 2024
Seed Round - Metsera
2-undefined

Recent Activity

There is no recent news or activity for this profile.